» Articles » PMID: 35617160

Cross-reactive Antibodies Targeting Surface-exposed Non-structural Protein 1 (NS1) of Dengue Virus-infected Cells Recognize Epitopes on the Spaghetti Loop of the β-ladder Domain

Abstract

Non-structural protein 1 (NS1) is a glycoprotein component of dengue virus (DENV) that is essential for viral replication, infection and immune evasion. Immunization with NS1 has been shown to elicit antibody-mediated immune responses which protect mice against DENV infections. Here, we obtained peripheral blood mononuclear cells from human subjects with secondary dengue infections, which were used to construct a dengue immune phage library displaying single-chain variable fragments. Phage selective for DENV NS1 were obtained by biopanning. Twenty-one monoclonal antibodies (mAbs) against DENV NS1 were generated from the selected phage and characterized in detail. We found most anti-NS1 mAbs used IGHV1 heavy chain antibody genes. The mAbs were classified into strongly and weakly-reactive groups based on their binding to NS1 expressed in dengue virus 2 (DENV2)-infected cells. Antibody binding experiments with recombinant NS1 proteins revealed that the mAbs recognize conformational epitopes on the β-ladder domain (amino acid residues 178-273) of DENV NS1. Epitope mapping studies on alanine-substituted NS1 proteins identified distinct but overlapping epitopes. Protruding amino acids distributed around the spaghetti loop are required for the binding of the strongly-reactive mAbs, whereas the recognition residues of the weakly-reactive mAbs are likely to be located in inaccessible sites facing toward the cell membrane. This information could guide the design of an NS1 epitope-based vaccine that targets cross-reactive conserved epitopes on cell surface-associated DENV NS1.

Citing Articles

An Engineered N-Glycosylated Dengue Envelope Protein Domain III Facilitates Epitope-Directed Selection of Potently Neutralizing and Minimally Enhancing Antibodies.

Nilchan N, Kraivong R, Luangaram P, Phungsom A, Tantiwatcharakunthon M, Traewachiwiphak S ACS Infect Dis. 2024; 10(8):2690-2704.

PMID: 38943594 PMC: 11320570. DOI: 10.1021/acsinfecdis.4c00058.


Nonstructural Proteins: The Role in Molecular Mechanisms of Triggering Inflammation.

Latanova A, Starodubova E, Karpov V Viruses. 2022; 14(8).

PMID: 36016430 PMC: 9414172. DOI: 10.3390/v14081808.

References
1.
Avirutnan P, Fuchs A, Hauhart R, Somnuke P, Youn S, Diamond M . Antagonism of the complement component C4 by flavivirus nonstructural protein NS1. J Exp Med. 2010; 207(4):793-806. PMC: 2856034. DOI: 10.1084/jem.20092545. View

2.
Avirutnan P, Hauhart R, Somnuke P, Blom A, Diamond M, Atkinson J . Binding of flavivirus nonstructural protein NS1 to C4b binding protein modulates complement activation. J Immunol. 2011; 187(1):424-33. PMC: 3119735. DOI: 10.4049/jimmunol.1100750. View

3.
Guy B, Saville M, Lang J . Development of Sanofi Pasteur tetravalent dengue vaccine. Hum Vaccin. 2010; 6(9). DOI: 10.4161.hv.6.9.12739. View

4.
Conde J, Silva E, Allonso D, Coelho D, Andrade I, de Medeiros L . Inhibition of the Membrane Attack Complex by Dengue Virus NS1 through Interaction with Vitronectin and Terminal Complement Proteins. J Virol. 2016; 90(21):9570-9581. PMC: 5068511. DOI: 10.1128/JVI.00912-16. View

5.
Alcon S, Talarmin A, Debruyne M, Falconar A, Deubel V, Flamand M . Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections. J Clin Microbiol. 2002; 40(2):376-81. PMC: 153354. DOI: 10.1128/JCM.40.02.376-381.2002. View